Results 131 to 140 of about 55,382 (272)

Documented Obstructive Sleep Apnea, Cardiometabolic Phenotype, and Rhythm‐Related Outcomes After Atrial Fibrillation Ablation: An Observational Cohort Study

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
Documented OSAS identified a higher‐risk cardiometabolic phenotype in patients undergoing AF ablation, including greater obesity, hypertension, diabetes, persistent AF, and adverse lipid markers. However, it did not independently predict post‐ablation rhythm‐related outcomes in either the registry cohort or the actively followed cohort.
Yazan Mohsen   +9 more
wiley   +1 more source

Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report

open access: yesTherapeutic Advances in Hematology
Polyethylene-glycolated Escherichia coli -derived l -asparaginase (pegaspargase, pASP) is an essential component of paediatric-inspired regimens for the treatment of acute lymphoblastic leukaemia/lymphoma; nonetheless, is characterised by severe and ...
Gaia Ciolli   +10 more
doaj   +1 more source

Hypertriglyceridemia and adverse outcomes during pregnancy [PDF]

open access: yes, 2018
Introduction: During pregnancy, levels of maternal serum triglycerides increase as a physiological adaptation mechanism to meet the needs of the developing fetus.
Cortés-Vásquez, Jonathan   +2 more
core  

Severe hypertriglyceridemia presenting as eruptive xanthomatosis

open access: yes, 2018
Eruptive xanthomatosis is described as the sudden eruption of erythematous yellow papules in the presence of hypertriglyceridemia, often associated with serum triglyceride levels above 2000 mg/dl.
Sameera S Vangara   +3 more
core   +1 more source

Cardiovascular–kidney–metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND

open access: yesAlzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract INTRODUCTION Whether cardiovascular–kidney–metabolic (CKM) syndrome stage modifies cognitive benefits of intensive blood pressure (BP) control remains unclear. METHODS This post hoc analysis of ‌Systolic Blood Pressure Intervention Trial – Memory and Cognition in Decreased Hypertension (SPRINT MIND) classified participants into non‐advanced ...
Zhongxiao Wang   +8 more
wiley   +1 more source

Development of hypertriglyceridemia in patients with enterocutaneous fistulas.

open access: yes, 2009
BACKGROUND & AIMS: Hypertriglyceridemia is commonly observed in patients with enterocutaneous fistulas, compromising their health status. In this study potential causes for hypertriglyceridemia in patients with an enterocutaneous fistula are explored and
Winkens, B.; id_orcid   +7 more
core   +1 more source

Therapeutic Potential of Berberis vulgaris in Modulating Metabolic Syndrome Biomarkers: Mechanistic Insights and Functional Food Implications

open access: yesFood Frontiers, Volume 7, Issue 4, July 2026.
ABSTRACT Barberry (Berberis vulgaris) has emerged as a promising functional food candidate for the management of metabolic syndrome due to its diverse bioactive constituents, particularly berberine. This review synthesizes current experimental and clinical evidence regarding its effects on glycemic control, lipid metabolism, blood pressure regulation ...
Fakhar Shahid   +5 more
wiley   +1 more source

Chinese herbal medicines for hypertriglyceridemia (Protocol)

open access: yes, 2012
The aim of this intervention protocol is to assess the effects and safety of herbal medicines for ...
Bensoussan, Alan (R7273)   +11 more
core   +1 more source

Nutritional characterization of Cusco green tea and its synergistic effect with omega‐3 on metabolic and cognitive dysfunctions in obese rats

open access: yesJournal of the Science of Food and Agriculture, Volume 106, Issue 9, Page 5643-5657, July 2026.
Abstract BACKGROUND Obesity and its metabolic complications, such as insulin resistance and cognitive decline, remain a global health challenge. Green tea (Camelia sinensis) and ω‐3 polyunsaturated fatty acids (PUFAs) are recognized for their antioxidant, anti‐inflammatory, and neuroprotective properties.
Paola Finetti‐Casanova   +5 more
wiley   +1 more source

Drug Interactions of Vebreltinib, a Novel Type I c‐Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants

open access: yesClinical and Translational Science, Volume 19, Issue 7, July 2026.
Pharmacokinetic and drug–drug interaction evaluation of vebreltinib in healthy participants, showing decreased exposure with rifampin and increased exposure with itraconazole. ABSTRACT Vebreltinib is a novel, highly selective type I c‐Met inhibitor developed for treating non–small cell lung cancer (NSCLC) and glioma.
Jingcheng Chen   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy